Search Results

Displaying Results 1-25 of 130186 "'OR'"

Jun 07, 2026, 00:08 ET Looney Tunes™ Land Now Open at Six Flags Magic Mountain

tower where Tweety causes chaos before riders bounce down in a wobbly, jiggly, giggly frenzy. Or, guests can decide how to soar whether a hot air balloon ride in a colorful basket on Looney Ballooneys or a propeller plane on Funny Flyers. Of course, don't miss the all-new show Vacation

More news about: Six Flags Magic Mountain


Jun 06, 2026, 20:23 ET The American Diabetes Association Announces Winners of the Innovation Challenge

cure diabetes—and we're not stopping. There are over 155 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at

More news about: American Diabetes Association


Jun 06, 2026, 18:13 ET From Bystanders to Heart Savers: MedStar Health CPR Training Event Puts Power to Save Lives in Community's Hands

three-quarters were unaware that using only chest compressions is an effective way to perform CPR.If performed immediately, bystander CPR can double, or even triple, a person's chance of survival from sudden cardiac arrest."CPR is extremely effective when administered quickly and correctly," said

More news about: MedStar Health


Jun 06, 2026, 17:50 ET SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

https://rosenlegal.com/cases/sportradar-group-ag/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class

More news about: THE ROSEN LAW FIRM, P. A.


Jun 06, 2026, 17:46 ET WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

https://www.rosenlegal.com/cases/genedx-holdings-corp/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class

More news about: THE ROSEN LAW FIRM, P. A.


Jun 06, 2026, 15:35 ET Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference

construction services all within a single-source solution. Ramtech can offer facilities built using permanent modular construction on both a pier and beam or concrete slab foundation. Both options combine the best of off-site manufacturing and on-site construction techniques to produce a building faster and

More news about: Ramtech Building Systems, Inc


Jun 06, 2026, 14:45 ET 82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

type 2 diabetes not on insulin (mean age 60; 32% racial or ethnic minority participants; A1C 7.1% to 14.9%). The trial evaluated the impact of CGM on blood glucose management and A1C levels (a way to understand blood glucose levels over the past two or three months) over 26 weeks. At baseline, mean A1C was

More news about: American Diabetes Association


Jun 06, 2026, 14:30 ET Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

yellowing of skin or eyes (jaundice), or clay-colored stools.Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Foundayo may increase the chance of food getting into your lungs during surgery or other procedures.

More news about: Eli Lilly and Company


Jun 06, 2026, 14:30 ET Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

2.5 years) and a BMI of ≥23 kg/m². Over 40 weeks, participants were randomly assigned to receive a once-weekly injection of 4 mg, 9 mg, or 12 mg of retatrutide, or placebo.Findings demonstrated that retatrutide achieved strong glucose control, significant improvements in A1C, and substantial weight

More news about: American Diabetes Association


Jun 06, 2026, 13:14 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

https://rosenlegal.com/submit-form/?case_id=51887 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class

More news about: THE ROSEN LAW FIRM, P. A.


Jun 06, 2026, 13:00 ET Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

events (cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with established CVD with overweight or obesity with no prior history of diabetes.10 In SELECT, established CVD was defined as a prior heart attack, prior stroke, or symptomatic PAD.10 The trial,

More news about: NOVO NORDISK INC.


Jun 06, 2026, 11:57 ET /C O R R E C T I O N -- U.S. Postal Service/

USA Philatelic or at Post Office locations nationwide. For officially licensed stamp products, shop the

More news about: U.S. Postal Service


Jun 06, 2026, 11:08 ET MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP

alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Medpace consistently oversold Medpace's projected book-to-bill ratio for fourth quarter 2025; (ii) Medpace knew or recklessly disregarded the impact that cancellations have on Medpace's

More news about: Robbins Geller Rudman & Dowd LLP


Jun 06, 2026, 11:06 ET In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care

protects healthy bone.These same principles apply in regenerative procedures as well. The article emphasizes that when the goal is to rebuild tissue or bone, accuracy is essential. Microsurgical techniques help create the conditions needed for rapid healing and tissue growth.Not every treatment

More news about: HelloNation


Jun 06, 2026, 11:00 ET MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - STLA

worldwide.The Stellantis class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Stellantis'

More news about: Robbins Geller Rudman & Dowd LLP


Jun 06, 2026, 10:30 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Simparica Trio.The Zoetis class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) veterinarian prescription growth and adoption of Zoetis' Librela, a canine pain treatment, were sharply weakening

More news about: Robbins Geller Rudman & Dowd LLP


Jun 06, 2026, 10:20 ET AVAV INVESTOR NOTICE: AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

conducting telemetry, or accessing data from satellites to assess their status and health, according to the complaint.The AeroVironment class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

More news about: Robbins Geller Rudman & Dowd LLP


Jun 06, 2026, 09:07 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

included were adults with type 2 diabetes with a prescription claim for semaglutide 1 mg with subsequent claims for either semaglutide 2 mg or tirzepatide 2.5 mg or 5 mg. The study included 64,888 adults in an HbA1c cohort and 56,852 in a weight‑loss cohort. As with all observational analyses,

More news about: Novo Nordisk


Jun 06, 2026, 09:01 ET People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

included were adults with type 2 diabetes with a prescription claim for semaglutide 1 mg with subsequent claims for either semaglutide 2 mg or tirzepatide 2.5 mg or 5 mg. The study included 64,888 adults in an HbA1c cohort and 56,852 in a weight‑loss cohort. As with all observational analyses,

More news about: Novo Nordisk


Jun 06, 2026, 09:00 ET Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) across patient populations—including in individuals with excess weight or obesity with or without type 2 diabetes—and dosage levels, ranging from weekly to monthly. The data were presented during symposium sessions at the 2026 Scientific

More news about: American Diabetes Association


Jun 06, 2026, 09:00 ET New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Association notes that high ketone levels can escalate to DKA within hours and, if left untreated, can lead to coma or death.2 Many people living with diabetes aren't familiar with DKA or its symptoms, despite clinical guidance recommending ketone testing during periods of elevated glucose, making

More news about: Abbott


Jun 06, 2026, 07:51 ET Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded

technology-driven world. And that's going to add lot of value to the students and to the nation and also to the industry because you will get learners or candidates who are prepared for the role that industry is looking out for."Parkar added, "If we look at as a firm we look at contributing to Viksit

More news about: Chandigarh University


Jun 06, 2026, 06:00 ET Leading Vision Insurance for Glasses (2026): VSP Individual Vision Plans Named Top Plan for Frames and Lens Coverage by Better Business Advice

lensesFor members seeking additional features, such as progressive lenses or anti-reflective coatings, plans may offer fixed copays or additional savings on upgrades. In some cases, enhanced plan options provide full or reduced-cost access to these features.This layered approach to lens coverage

More news about: BetterBusinessAdvice.com


Jun 05, 2026, 23:03 ET PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses to Lead the PicS N.V. Class Action Lawsuit

million.The PicS N.V. class action lawsuit alleges that defendants in the IPO's offering documents made false and/or misleading statements and/or failed to disclose that: (i) PicS N.V. had conducted an evaluation of its credit evaluation procedures in December 2025 and determined

More news about: Robbins Geller Rudman & Dowd LLP


Jun 05, 2026, 22:12 ET NYT Investors Have the Opportunity to Join Investigation of The New York Times Company with the Schall Law Firm

shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in The New York Times Company ("New York Times" or "the Company") (NYSE:

More news about: The Schall Law Firm


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.